FREDERICK, MD., (April 29, 2025) —RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services, announced a new collaboration with Thermo Fisher Scientific, the world leader in serving science. This collaboration aims to accelerate the availability of new, potentially life-saving cell and exosome therapies that have the potential to revolutionize the treatment of degenerative disease. [Read more…]
Exosome Research: Who Is Dominating in the Scientific Literature?
Exosome research is experiencing rapid growth, driven by the increasing recognition of their critical role in intercellular communication and molecular transport. These extracellular vesicles act as natural carriers of proteins, lipids, and genetic material, influencing a wide range of physiological and pathological processes. As a result, they are emerging as a promising tool in regenerative medicine, drug delivery, and disease diagnostics.
Beyond their biological significance, exosomes are attracting attention for their potential therapeutic applications. Because they can mediate many of the beneficial effects traditionally associated with cells—without the same risks of immune rejection or uncontrolled proliferation—they are increasingly attracting attention and investment. [Read more…]
Dr. Askenase on the Role of MSC-Derived Exosomes in Healing the Injured Spinal Cord
This interview features Dr. Philip Askenase, MD, a Professor of Medicine and Pathology at Yale University School of Medicine. A leading expert in the effector properties of exosomes, Dr. Askenase is now delving into the regenerative potential of mesenchymal stem cell (MSC)-derived exosomes.
His latest, as-yet-unpublished research focuses on using MSC-derived exosomes to promote healing in injured spinal cords in rats. In our conversation, we examine the expanding significance of MSC-derived exosomes, their unique advantages, and diverse applications. We also discuss the market opportunities for stem cell exosomes and the companies driving innovation in this emerging field.
Funding Flows Freely into Exosome Therapeutics in 2025
The therapeutic applications of exosomes, particularly those derived from stem cells and cancer cells, continue to expand in 2025, driving accelerated innovation in this dynamic market. Emerging trends highlight the potential of exosomes as both diagnostic tools and cell-free therapeutics, with increasing applications across diverse fields such as oncology, neurology, and regenerative medicine. In parallel, a growing number of life science companies are providing advanced tools and reagents to support exosome research, reflecting the sector’s rapid growth. [Read more…]
Opening Cancer’s Mail: Cancer Exosomes Contain “Inventory of Intent”
Currently over 50% of men and women are directed to unnecessary treatment or surgery. A new approach may help. Professor Alan Doucette of Dalhousie University and his colleagues have published a study funded by the Breast Cancer Society of Canada in which they capture particles released by rapidly growing cells called exosomes. Like parcels containing tools and instructions, exosomes contain an “inventory of intent.” Meaning, the cells that have released them contain genetic material proteins and metabolites that promote invasion of normal cells and commandeer their resources. [Read more…]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 12
- Next Page »